Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade II Glioma”

324 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 324 results

Testing effectiveness (Phase 2)Study completedNCT00070525
What this trial is testing

Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma

Who this might be right for
Childhood High-grade Cerebral AstrocytomaChildhood OligodendrogliomaRecurrent Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Large-scale testing (Phase 3)Looking for participantsNCT05331521
What this trial is testing

A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).

Who this might be right for
Oligodendroglioma
University Hospital Heidelberg 406
Testing effectiveness (Phase 2)Study completedNCT01158651
What this trial is testing

Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas

Who this might be right for
Glioma
University of Alabama at Birmingham 23
Testing effectiveness (Phase 2)Ended earlyNCT01011231
What this trial is testing

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Who this might be right for
Glioblastoma
University of California, San Francisco 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06678867
What this trial is testing

The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours

Who this might be right for
Brain Tumor
University College, London 80
Testing effectiveness (Phase 2)Ended earlyNCT02332889
What this trial is testing

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Who this might be right for
GliomasMedulloblastomaNeuroectodermal Tumors, Primitive
University of Louisville 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07703436
What this trial is testing

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

Who this might be right for
Grade 2 IDH1-mutant GliomaGrade 3 IDH1-mutant GliomaGlioma+5 more
Nuvation Bio Inc. 40
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Testing effectiveness (Phase 2)Study completedNCT00114140
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 136
Testing effectiveness (Phase 2)Study completedNCT00293423
What this trial is testing

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 96
Testing effectiveness (Phase 2)Study completedNCT00629889
What this trial is testing

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsSeizure
Dr Andrea Rossetti 52
Not applicableActive Not RecruitingNCT06969352
What this trial is testing

A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)

Who this might be right for
Gliomas
Servier (Tianjin) Pharmaceutical Co. LTD. 62
Testing effectiveness (Phase 2)Study completedNCT03027388
What this trial is testing

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)Ended earlyNCT00243022
What this trial is testing

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System TumorsCerebral Edema
Ali Altunkaya 12
Testing effectiveness (Phase 2)Looking for participantsNCT07243470
What this trial is testing

Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

Who this might be right for
GliomaCNS Tumor, AdultCNS Tumor, Childhood
Centre Leon Berard 70
Testing effectiveness (Phase 2)Study completedNCT02971319
What this trial is testing

Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

Who this might be right for
Glioma (Diagnosis)
Proactina S.A. 32
Next Page